Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
Open Access
Abstract
Autophagy-related genes (ATGs) depress tumorigenesis. However, in tumor tissue, it promotes tumor progression. Here, we demonstrated that 63 ATGs were differentially expressed in normal tissues and tumor tissues of hepatocellular carcinoma (HCC), and seven prognostic-related genes were chosen to establish prognostic risk signatures. It is not just an independent prognostic factor for HCC, but also closely related to the degree of malignancy of HCC. Further, the hallmarks of PI3K–AKT–mTOR signaling was significantly enriched in the high-risk group. Moreover, AKT–pS473 and mTOR–pS2448 expression was down-regulated and correlated with patient prognosis in high-risk group. Finally, we demonstrate that the prognosis signature of ATGs is closely related to immune cell infiltration and PD-L1 expression. In conclusion, ATGs are a crucial factor in the malignant progression of HCC and will be a new prognostic marker for diagnosis and treatment. ATGs prognostic signatures are potentially useful for predicting PD-L1 therapeutic effects.Keywords
Funding Information
- National Science Foundation of China (31770985)
- Social development project of Jiangsu province (BE2019665)
- Postdoctoral Science Foundation Grant of China (2016M591913)
- Jiangsu Provincial Medical Youth Talent (QNRC2016732)
- Jiangsu Provincial “Six Peaks Talent” Program (2016-WSW-043)
- Suzhou Municipal Project of Gusu Health Talent, Young Top Talent (2018-057)
- Gusu Health Talents Cultivation Program (GSWS2019028)
- Scientific Research Program of Jiangsu Provincial “333 Projects” (BRA2019327)
- Science and Technology Program of Suzhou City, China (SYS2019053 and SLC201906)
- Provincial Natural Science Foundation of Jiangsu Province (BK20161225)
- Scientific Research Program of Jiangsu Provincial Commission of Health and Family Planning (H201620)
This publication has 37 references indexed in Scilit:
- Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)Journal for ImmunoTherapy of Cancer, 2018
- Autophagy-related gene expression in colorectal cancer patients.2017
- SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathwayBritish Journal of Cancer, 2017
- mTOR and autophagy: A dynamic relationship governed by nutrients and energySeminars in Cell & Developmental Biology, 2014
- Mechanisms of disseminated cancer cell dormancy: an awakening fieldNature Reviews Cancer, 2014
- Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell deathBritish Journal of Cancer, 2014
- The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targetsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013
- Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagyCancer Biology & Therapy, 2011
- A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma†Hepatology, 2010
- Selection of important variables and determination of functional form for continuous predictors in multivariable model buildingStatistics in Medicine, 2007